Selected research
Industry Research
Felbinac Industry Research Report 2026
Market perspective
The global Felbinac market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Felbinac is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Felbinac is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Felbinac is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Felbinac include Meryer, Hua Luo, FREDA, TripleBond, LGC Standard, BLD Pharm, Aurum Pharmatech, Anward and Aba Chem Scene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Felbinac market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Felbinac Market by Company
Meryer
Hua Luo
FREDA
TripleBond
LGC Standard
BLD Pharm
Aurum Pharmatech
Anward
Aba Chem Scene
Felbinac Segment by Type
98% Purity Type
97% Purity Type
Others
Felbinac Segment by Application
Felbinac Tincture
Felbinac Gel
Felbinac Patch
Others
Felbinac Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felbinac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Felbinac and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felbinac.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Felbinac manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Felbinac by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Felbinac in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 98% Purity Type
- 97% Purity Type
- Others
Applications
- Felbinac Tincture
- Felbinac Gel
- Felbinac Patch
- Others
Companies covered
- Meryer
- Hua Luo
- FREDA
- TripleBond
- LGC Standard
- BLD Pharm
- Aurum Pharmatech
- Anward
- Aba Chem Scene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Felbinac Market Size (2021-2032)
- 2.2.2 Global Felbinac Sales (2021-2032)
- 2.2.3 Global Felbinac Market Average Price (2021-2032)
- 2.3 Felbinac by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 98% Purity Type
- 2.3.3 97% Purity Type
- 2.3.4 Others
- 2.4 Felbinac by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Felbinac Tincture
- 2.4.3 Felbinac Gel
- 2.4.4 Felbinac Patch
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Felbinac Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Felbinac Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Felbinac Revenue of Manufacturers (2021-2026)
- 3.4 Global Felbinac Average Price by Manufacturers (2021-2026)
- 3.5 Global Felbinac Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Felbinac, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Felbinac, Product Type & Application
- 3.8 Global Manufacturers of Felbinac, Established Date
- 3.9 Global Felbinac Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Meryer
- 4.1.1 Meryer Company Information
- 4.1.2 Meryer Business Overview
- 4.1.3 Meryer Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Meryer Felbinac Product Portfolio
- 4.1.5 Meryer Recent Developments
- 4.2 Hua Luo
- 4.2.1 Hua Luo Company Information
- 4.2.2 Hua Luo Business Overview
- 4.2.3 Hua Luo Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hua Luo Felbinac Product Portfolio
- 4.2.5 Hua Luo Recent Developments
- 4.3 FREDA
- 4.3.1 FREDA Company Information
- 4.3.2 FREDA Business Overview
- 4.3.3 FREDA Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 FREDA Felbinac Product Portfolio
- 4.3.5 FREDA Recent Developments
- 4.4 TripleBond
- 4.4.1 TripleBond Company Information
- 4.4.2 TripleBond Business Overview
- 4.4.3 TripleBond Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TripleBond Felbinac Product Portfolio
- 4.4.5 TripleBond Recent Developments
- 4.5 LGC Standard
- 4.5.1 LGC Standard Company Information
- 4.5.2 LGC Standard Business Overview
- 4.5.3 LGC Standard Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LGC Standard Felbinac Product Portfolio
- 4.5.5 LGC Standard Recent Developments
- 4.6 BLD Pharm
- 4.6.1 BLD Pharm Company Information
- 4.6.2 BLD Pharm Business Overview
- 4.6.3 BLD Pharm Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BLD Pharm Felbinac Product Portfolio
- 4.6.5 BLD Pharm Recent Developments
- 4.7 Aurum Pharmatech
- 4.7.1 Aurum Pharmatech Company Information
- 4.7.2 Aurum Pharmatech Business Overview
- 4.7.3 Aurum Pharmatech Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Aurum Pharmatech Felbinac Product Portfolio
- 4.7.5 Aurum Pharmatech Recent Developments
- 4.8 Anward
- 4.8.1 Anward Company Information
- 4.8.2 Anward Business Overview
- 4.8.3 Anward Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Anward Felbinac Product Portfolio
- 4.8.5 Anward Recent Developments
- 4.9 Aba Chem Scene
- 4.9.1 Aba Chem Scene Company Information
- 4.9.2 Aba Chem Scene Business Overview
- 4.9.3 Aba Chem Scene Felbinac Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Aba Chem Scene Felbinac Product Portfolio
- 4.9.5 Aba Chem Scene Recent Developments
5 Global Felbinac Market Scenario by Region
- 5.1 Global Felbinac Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Felbinac Sales by Region: 2021-2032
- 5.2.1 Global Felbinac Sales by Region: 2021-2026
- 5.2.2 Global Felbinac Sales by Region: 2027-2032
- 5.3 Global Felbinac Revenue by Region: 2021-2032
- 5.3.1 Global Felbinac Revenue by Region: 2021-2026
- 5.3.2 Global Felbinac Revenue by Region: 2027-2032
- 5.4 North America Felbinac Market Facts & Figures by Country
- 5.4.1 North America Felbinac Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Felbinac Sales by Country (2021-2032)
- 5.4.3 North America Felbinac Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Felbinac Market Facts & Figures by Country
- 5.5.1 Europe Felbinac Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Felbinac Sales by Country (2021-2032)
- 5.5.3 Europe Felbinac Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Felbinac Market Facts & Figures by Country
- 5.6.1 Asia Pacific Felbinac Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Felbinac Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Felbinac Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Felbinac Market Facts & Figures by Country
- 5.7.1 South America Felbinac Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Felbinac Sales by Country (2021-2032)
- 5.7.3 South America Felbinac Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Felbinac Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Felbinac Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Felbinac Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Felbinac Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Felbinac Sales by Type (2021-2032)
- 6.1.1 Global Felbinac Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Felbinac Sales Market Share by Type (2021-2032)
- 6.2 Global Felbinac Revenue by Type (2021-2032)
- 6.2.1 Global Felbinac Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Felbinac Revenue Market Share by Type (2021-2032)
- 6.3 Global Felbinac Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Felbinac Sales by Application (2021-2032)
- 7.1.1 Global Felbinac Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Felbinac Sales Market Share by Application (2021-2032)
- 7.2 Global Felbinac Revenue by Application (2021-2032)
- 7.2.1 Global Felbinac Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Felbinac Revenue Market Share by Application (2021-2032)
- 7.3 Global Felbinac Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Felbinac Value Chain Analysis
- 8.1.1 Felbinac Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Felbinac Production Mode & Process
- 8.2 Felbinac Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Felbinac Distributors
- 8.2.3 Felbinac Customers
9 Global Felbinac Analyzing Market Dynamics
- 9.1 Felbinac Industry Trends
- 9.2 Felbinac Industry Drivers
- 9.3 Felbinac Industry Opportunities and Challenges
- 9.4 Felbinac Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst